Ben Locwin, PhD, MS, MBA

All articles by Ben Locwin, PhD, MS, MBA

feature

There has been an ongoing evolution in the treatment of psychosis, schizophrenia, bipolar, and other significant psychiatric morbidities. As therapies have evolved, efficacy in treating positive and negative symptoms has (for the most part) remained quite high, and there has been a concerted push to — as the generations of drugs progress ever-forward — reduce the off-target and unwanted side effects of treatment (which also helps to boost compliance with medication-taking behaviors). Dr Ben Locwin shares his expertise on the future of pharmacologic treatment.